AI assistant
HAEMONETICS CORP — Director's Dealing 2024
May 21, 2024
31565_dirs_2024-05-21_0832e866-7fa2-4952-99f8-f098575d0c52.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2024-05-17
Reporting Person: Strong Stewart W (President, Global Hospital)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-05-17 | Common Stock | F | 284 | $95.73 | Disposed | 15324 | Direct |
| 2024-05-17 | Common Stock | A | 2872 | — | Acquired | 18196 | Direct |
| 2024-05-20 | Common Stock | M | 2241 | $56.57 | Acquired | 20437 | Direct |
| 2024-05-20 | Common Stock | F | 1555 | $95.08 | Disposed | 18882 | Direct |
| 2024-05-20 | Common Stock | S | 686 | $95.11 | Disposed | 18196 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | Non-qualified Stock Option (Right to Buy) | $95.73 | A | 6313 | Acquired | 2031-05-17 | Common Stock (6313) | Direct |
| 2024-05-20 | Non-qualified Stock Option (Right to Buy) | $56.57 | M | 2241 | Disposed | 2028-05-18 | Common Stock (2241) | Direct |
Footnotes
F1: Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.
F2: This number includes unvested RSUs previously reported.
F3: The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant.
F4: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
F5: Transaction pursuant to an existing 10b5-1 trading plan dated June 12, 2023 (fully executed as of June 12, 2023).
F6: Represents shares withheld for tax obligations and for payment of the exercise price on exercised stock options reported in Table I.
F7: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.
F8: Reflects options granted on May 18, 2021 that vest in annual increments of 25% beginning on the first anniversary of the date of grant.